Artemis Hospitals
From AUD $22,300. Total expenses depend on the extent of cancer resection required, the specific chemotherapy agents used, and the length of ICU stay. Australian patients can save approximately 74% compared to local private costs, which average AUD $84,700. Pricing usually includes the surgical procedure, anaesthetic, and the heated chemotherapy perfusion process.
Bookimed Expert Insight: Indian oncology centres offer high value for complex cases through specialised surgical expertise. Dr Raj Nagarkar, for example, has performed over 50,000 cancer surgeries. Clinics like Manipal Hospitals and Global Hospital Chennai hold JCI and NABH accreditations, ensuring quality standards. Some facilities also use advanced planning tools like IBM Watson for oncology to refine treatment protocols. This combination of vast clinical experience and international accreditation provides a reliable alternative for patients facing long Australian waitlists.
| India | Thailand | Turkey | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from AUD $22,300 | ≈ AUD $19,400 | from AUD $25,900 |
No hidden fees – just official clinic prices. Pay at the clinic for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hyperthermic Intraperitoneal Chemotherapy (HIPEC) journey.
Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.
Dr. Shruti Kate is a medical oncologist at HCG Manavata Cancer Centre in Nashik. She previously worked as a consultant at the Tata Memorial Hospital in Mumbai. Dr. Kate focuses on immunotherapy and metronomic therapy for treating solid and pediatric tumors. She was the sole recipient from India of the 2018 World Conference on Lung Cancer award.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.
The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.